Canada markets closed

Parnell Pharmaceuticals Holdings Ltd (PARNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 12:07PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.87M
Enterprise Value 23.87M
Trailing P/E 47.03
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.32
Price/Book (mrq)N/A
Enterprise Value/Revenue 0.90
Enterprise Value/EBITDA 2.39

Trading Information

Stock Price History

Beta (5Y Monthly) 20.10
52-Week Change 3-96.00%
S&P500 52-Week Change 325.59%
52 Week High 30.0200
52 Week Low 30.0000
50-Day Moving Average 30.0001
200-Day Moving Average 30.0003

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 518.15M
Implied Shares Outstanding 628.67B
Float 8N/A
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Dec 15, 2016) 427.41k
Short Ratio (Dec 15, 2016) 40.29
Short % of Float (Dec 15, 2016) 40.42%
Short % of Shares Outstanding (Dec 15, 2016) 40.21%
Shares Short (prior month Nov 15, 2016) 442.91k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sept 30, 2019

Profitability

Profit Margin -4.16%
Operating Margin (ttm)55.44%

Management Effectiveness

Return on Assets (ttm)6.47%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)34.17M
Revenue Per Share (ttm)1.18
Quarterly Revenue Growth (yoy)54.40%
Gross Profit (ttm)N/A
EBITDA 6M
Net Income Avi to Common (ttm)-1.42M
Diluted EPS (ttm)0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.68M
Total Cash Per Share (mrq)0.12
Total Debt (mrq)50.78M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.98
Book Value Per Share (mrq)-1.17

Cash Flow Statement

Operating Cash Flow (ttm)5.45M
Levered Free Cash Flow (ttm)-1.06M